ZME Science on MSN
British Scientists Are About to Test a Vaccine Designed to Stop Lung Cancer Before It Starts
In summer 2026, scientists at the University of Oxford and University College London plan to begin a first-of-its-kind ...
Foundation funds five new research projects, bringing 2025 total to $5.2 millionNEW YORK, Jan. 6, 2026 /PRNewswire/ -- The ...
Aktis Oncology, Inc. targets $200M IPO to advance radiopharmaceuticals for solid tumors. Click for more on the upcoming AKTS ...
Glomus tumours are uncommon, typically benign neoplasms of specialised dermal thermoregulatory structures known as glomus ...
Multidimensional intervention for patients with lung cancer incorporates rehabilitation, psychosocial support, nutrition guidance, health promotion, and safety surveillance. Multidimensional ...
The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...
The analyses of progression-free survival (PFS) and overall survival (OS) remain on track for late Q1 2026 in the ongoing Phase 2/3 COMPANION-002 ...
No significant differences in survival were found at 1 or 2 years among veterans with vs without rheumatoid arthritis receiving ICIs as cancer treatment. Patients with rheumatoid arthritis (RA) who ...
Encouraging anti-tumour activity seen across all dose levels and in various tumour indications Clinical benefit rate of 80% ...
A Comprehensive OverviewThe global Peptide Cancer Vaccine Market is valued at USD 1.2 Billion in 2025 and is projected to reach a value of USD 15.72 Billion by 2035 at a CAGR (Compound Annual Growth ...
Intrapleural enzyme therapy (IET) improves outcomes in adult inpatients with complicated parapneumonic pleural effusion or empyema.
Peter Voorhees, MD, emphasizes the importance of carefully determined early regimens for smoldering myeloma and involving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback